Home
Orbimed Advisors reported a 4.2% stake in Vistagen Therapeutics VTGN · 1,639,700 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 4.2%
- Last report
- 5.34% · filed 25/11/14
- Shares held
- 1,639,700 sh
- Class
- Common Stock, par value $0.001 per share
- Holder
- Orbimed Advisors
- Event date
- 25/12/31
- Filed
- 26/02/17
4.2% stake · below 5%
- Stake
- 4.2%
- Last report
- 5.34%
- Since last report
- −1.1pp
Vistagen Therapeutics trades, last 26 weeks
What else happened in Vistagen Therapeutics around then
Filed or reported within 30 days of the trade day · 25/12/01~01/30Orbimed Advisors's other 5% stake reports
- Orbimed Advisors
5% stakeADARx Pharmaceuticals
5% stakeADARx Pharmaceuticals
ADRX
14% stake
14,913,764 sh
14% stake
Filed 10/02
- Orbimed Advisors
5% stakeElectra Therapeutics
5% stakeElectra Therapeutics
ETRA
11% stake
6,885,170 sh
11% stake
Filed 09/25
- Orbimed Advisors
5% stakeBraveheart Bio
5% stakeBraveheart Bio
BRVE
13.5% stake
12,175,159 sh
13.5% stake
Filed 09/10
- Orbimed Advisors
5% stakeBraveheart Bio
5% stakeBraveheart Bio
BRVE
17.2% stake
12,175,159 sh
17.2% stake
Filed 08/18
- Orbimed Advisors
5% stakeBlossomHill Therapeutics
5% stakeBlossomHill Therapeutics
BLSM
8.9% stake
2,714,279 sh
8.9% stake
Filed 08/18
